Brind.
  1. Pfizer sought FDA approval for COVID-19 products, while Albert Bourla became CEO and successfully led the company through various stages, including acquisitions.

Pfizer CFO Dave Denton is leaving the company.

6 reports, 6 independent Updated Jun 18
Gone quiet Reached 6 outlets in its first 24 hours
Reports
6
Developments
2
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 6 independent outlets

Pfizer CFO Dave Denton is leaving the company.

Who's involved

What this event is mainly about
PfizerDave Denton

How it developed

Newest first. Tap a step to see who reported it.
  1. Pfizer CFO Dave Denton is departing the company.1 source
  2. Cecile appointed Interim CFO of Pfizer following Dave Denton's departure.1 source

Keep exploring

Part of

Pfizer sought FDA approval for COVID-19 products, while Albert Bourla became CEO and successfully led the company through various stages, including acquisitions. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped